OSTEOPOROSIS: IS IT TIME TO TREAT-TO-TARGET

被引：0
|
作者：
Lewiecki, M. [1 ]
机构：
[1] Univ New Mexico, Albuquerque, NM 87131 USA
来源：
OSTEOPOROSIS INTERNATIONAL | 2014年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
IS5
引用
收藏
页码：S660 / S660
页数：1
相关论文
共 50 条
  • [31] Treat-to-target in PsA: methods and necessity
    Dures, Emma
    Shepperd, Sasha
    Mukherjee, Sandeep
    Robson, Jo
    Vlaev, Ivo
    Walsh, Nicola
    Coates, Laura C.
    RMD OPEN, 2020, 6 (01):
  • [32] Treat-to-target as an approach in inflammatory arthritis
    Smolen, Josef S.
    CURRENT OPINION IN RHEUMATOLOGY, 2016, 28 (03) : 297 - 302
  • [33] Treat-to-Target in Pediatric Rheumatic Diseases
    Silvia Rosina
    Ana Isabel Rebollo-Giménez
    Alessandro Consolaro
    Angelo Ravelli
    Current Rheumatology Reports, 2023, 25 : 226 - 235
  • [34] TREAT TO TARGET IN OSTEOPOROSIS
    Cooper, Cyrus
    RHEUMATOLOGY, 2017, 56 : 1 - 2
  • [35] Is a treat-to-target strategy in osteoporosis applicable in clinical practice? Consensus among a panel of European experts
    Thomas, T.
    Casado, E.
    Geusens, P.
    Lems, W. F.
    Timoshanko, J.
    Taylor, D.
    Hofbauer, L. C.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (12) : 2303 - 2311
  • [36] Is a treat-to-target strategy in osteoporosis applicable in clinical practice? Consensus among a panel of European experts
    T. Thomas
    E. Casado
    P. Geusens
    W. F. Lems
    J. Timoshanko
    D. Taylor
    L. C. Hofbauer
    Osteoporosis International, 2020, 31 : 2303 - 2311
  • [37] Treat-to-target for polyarticular juvenile idiopathic arthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2020, 2 (06): : E322 - E322
  • [38] Gout: thoughts about a treat-to-target programme
    Braun, J.
    Smolen, J. S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (04) : S142 - S144
  • [39] Systemic lupus erythematosus: An update on treat-to-target
    Roberts, Amy Lynn
    Rizzolo, Denise
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2015, 28 (09): : 22 - 28
  • [40] Treat-to-target in rheumatoid arthritis — are we there yet?
    Ronald van Vollenhoven
    Nature Reviews Rheumatology, 2019, 15 : 180 - 186
12345